KCT0007902
Not yet recruiting
未知
Adequate infusion rate of remimazolam for induction of general anesthesia in elderly patients aged 65 or older
ConditionsNot Applicable
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not Applicable
- Sponsor
- Samsung Medical Center
- Enrollment
- 50
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Americal Society of Anesthesiologists physical status I \- III
- •2\) Aged 65 years and more
- •3\) Elective surgery under general anesthesia
Exclusion Criteria
- •1\) patients who are contraindicated in benzodiazepine (e,g., allergy to drug or have a history of hypersensitivity reactions)
- •2\) drug or alcohol addiction
- •3\) neuromuscular disease or mental illness
- •4\) metabolic disease
- •5\) emergency surgery
- •6\) body mass index \>30kg/m2 or \<18\.5kg/m2
- •7\) patient's refusal
- •8\) patients in shock or coma
- •9\) patients who are contraindicated to remiamazolam such as acute narrow\-angle glaucoma, sleep apnea, severe or acute respiratory failure, galactose intolerance, lactase deficiency, glucose\-galactose malabsorption, severe hypersensitivity to dextran 40\.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Adequate infusion rate of remimazolam for induction of general anesthesia in adult patientsKCT0006805Samsung Medical Center44
Completed
Phase 3
Remimazolam Bolus for General AnesthesiaLoss of ConsciousnessNCT04901871Gangnam Severance Hospital120
Recruiting
Not Applicable
Safety and efficacy of remimazolam in induction and maintenance of general anesthesia in children.peadatric patients undergoing general anesthesiaJPRN-UMIN000044630Saitama Children's Medical Center500
Not yet recruiting
Phase 4
Continuous infusion of remimazolam for intraoperative sedation as a safe and effective option: a prospective clinical study.Procedural or intraoperative sedation.Anaesthesiology - AnaestheticsACTRN12623000133639Antonia Kustura, MD50
Not yet recruiting
Not Applicable
Optimal Dose of Remimazolam for Sedation During Spinal Anesthesia in Age 60+: A Preliminary StudyDiseases of the musculoskeletal system and connective tissueKCT0007075Korea University Anam Hospital20